X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1799) 1799
Publication (243) 243
Book Review (19) 19
Magazine Article (17) 17
Newsletter (10) 10
Book Chapter (4) 4
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1529) 1529
antimalarials - therapeutic use (1126) 1126
mefloquine (932) 932
mefloquine - therapeutic use (827) 827
malaria (775) 775
male (765) 765
female (733) 733
animals (723) 723
malaria, falciparum - drug therapy (657) 657
adult (655) 655
index medicus (583) 583
tropical medicine (490) 490
plasmodium falciparum - drug effects (482) 482
drug resistance (480) 480
adolescent (423) 423
malaria - drug therapy (403) 403
child (399) 399
middle aged (363) 363
plasmodium falciparum (363) 363
drug therapy, combination (359) 359
infectious diseases (339) 339
parasitic diseases (321) 321
chloroquine - therapeutic use (319) 319
artemisinins - therapeutic use (311) 311
parasitology (308) 308
antimalarials - pharmacology (303) 303
drug combinations (302) 302
malaria - prevention & control (301) 301
chloroquine (297) 297
antimalarials - adverse effects (292) 292
public, environmental & occupational health (290) 290
child, preschool (285) 285
treatment outcome (267) 267
antimalarials - administration & dosage (263) 263
mefloquine - adverse effects (243) 243
pharmacology & pharmacy (243) 243
research (238) 238
travel (234) 234
antimalarials (231) 231
thailand (226) 226
artesunate (225) 225
sesquiterpenes - therapeutic use (225) 225
drug therapy (215) 215
medicine, general & internal (215) 215
pyrimethamine - therapeutic use (209) 209
malaria, falciparum - parasitology (206) 206
plasmodium-falciparum (205) 205
infant (196) 196
efficacy (195) 195
sulfadoxine - therapeutic use (194) 194
mefloquine - administration & dosage (187) 187
microbiology (185) 185
plasmodium-falciparum malaria (184) 184
children (180) 180
parasites (180) 180
artemisinins (176) 176
malaria, falciparum - epidemiology (174) 174
mefloquine - pharmacology (174) 174
quinolines - therapeutic use (165) 165
artemisinin (162) 162
malaria, falciparum - prevention & control (157) 157
pregnancy (153) 153
plasmodium falciparum - genetics (150) 150
health aspects (148) 148
quinine - therapeutic use (142) 142
artemether-lumefantrine (141) 141
drugs (141) 141
aged (140) 140
proguanil - therapeutic use (135) 135
resistance (129) 129
prophylaxis (128) 128
artemether (126) 126
mice (123) 123
infectious and parasitic diseases (121) 121
arctic medicine. tropical medicine (119) 119
antimalarials - pharmacokinetics (118) 118
pharmacokinetics (117) 117
young adult (117) 117
artemisinins - administration & dosage (113) 113
combination (112) 112
sulfadoxine-pyrimethamine (112) 112
infections (110) 110
chloroquine - pharmacology (108) 108
africa (107) 107
risk factors (107) 107
plasmodium falciparum - isolation & purification (106) 106
parasitemia - drug therapy (105) 105
in-vitro (101) 101
prevention (100) 100
quinine (100) 100
public health (99) 99
artesunate-mefloquine (94) 94
malaria - parasitology (93) 93
artemisinins - pharmacology (90) 90
pyrimethamine (90) 90
time factors (90) 90
travelers (89) 89
immunology (88) 88
malaria - epidemiology (88) 88
care and treatment (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1683) 1683
French (77) 77
German (22) 22
Spanish (10) 10
Portuguese (8) 8
Chinese (6) 6
Russian (5) 5
Hebrew (4) 4
Dutch (3) 3
Italian (3) 3
Japanese (3) 3
Turkish (2) 2
Czech (1) 1
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9918, pp. 723 - 735
Summary Although global morbidity and mortality have decreased substantially, malaria, a parasite infection of red blood cells, still kills roughly 2000 people... 
Internal Medicine | VIVAX MALARIA | MEDICINE, GENERAL & INTERNAL | MALAWIAN CHILDREN | CHILDHOOD CEREBRAL MALARIA | SUB-SAHARAN AFRICA | RANDOMIZED-TRIAL | ACUTE-RENAL-FAILURE | INFECTED ERYTHROCYTES | PLASMODIUM-FALCIPARUM MALARIA | VON-WILLEBRAND-FACTOR | PROSPECTIVE COHORT | Malaria, Falciparum | Malaria, Vivax | Pregnancy Complications, Infectious - parasitology | Humans | Asia, Southeastern - epidemiology | Pregnancy Complications, Infectious - physiopathology | Quinine - therapeutic use | Insecticide-Treated Bednets | Mefloquine - therapeutic use | Malaria - epidemiology | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Female | Seasons | Amodiaquine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Insecticides - pharmacology | Pyrimethamine - therapeutic use | Drug Administration Schedule | Pregnancy Complications, Infectious - epidemiology | Chloroquine - therapeutic use | Malaria - diagnosis | Antimalarials - therapeutic use | Malaria - prevention & control | Pregnancy | Anopheles | Animals | Artemisinins - therapeutic use | Malaria Vaccines - administration & dosage | Malaria - pathology | Pregnancy Complications, Infectious - drug therapy | Primary Prevention - methods | Malaria - physiopathology | Malaria - complications | Quinolines - therapeutic use | Malaria - drug therapy | Africa South of the Sahara - epidemiology | Drug Combinations | Prognosis | Research | Malaria | Epidemiology | Distribution | Plasmodium falciparum | Medical research | Parasitic diseases | Mortality | Africa | Antimalarials | Medicine, Experimental | Insecticides | Mosquitoes | Microscopy | Ligands | Parasites | Blood
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2018, Volume 11, Issue 11, p. CD011444
Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all... 
Abortion, Spontaneous [chemically induced; epidemiology] | HIV Infections [complications] | ANTIMALARIAL AGENTS | Africa South of the Sahara [epidemiology] | EFFICACY | LOW-BIRTH-WEIGHT | Humans | Trimethoprim | SULFADOXINE-PYRIMETHAMINE RESISTANCE | Thailand [epidemiology] | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | Insecticide-Treated Bednets | Parasitemia [epidemiology] | Combination | PLASMODIUM-FALCIPARUM | INFANTS | Female | INFECTION | Pregnancy Complications, Parasitic [epidemiology; prevention & control] | Infant, Low Birth Weight | Mefloquine [adverse effects; therapeutic use] | Drug Therapy | RISK | Antimalarials [adverse effects; therapeutic use] | Dizziness [chemically induced; epidemiology] | Randomized Controlled Trials as Topic | Sulfadoxine [adverse effects; therapeutic use] | Pregnancy | Malaria [epidemiology; prevention & control] | HIV | Vomiting [chemically induced; epidemiology] | Sulfamethoxazole Drug Combination [therapeutic use] | Drug Combinations | Pyrimethamine [adverse effects; therapeutic use] | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | HIV Seronegativity | Placenta Diseases - epidemiology | Anemia - epidemiology | Pregnancy Complications, Infectious - epidemiology | Stillbirth | Antimalarials - therapeutic use | Parasitemia - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Placenta Diseases - parasitology | Mefloquine - adverse effects | Malaria - prevention & control | Vomiting - chemically induced | Mefloquine - therapeutic use | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Pregnancy Complications - chemically induced | Drug Therapy, Combination
Journal Article
Journal Article